<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00288717</url>
  </required_header>
  <id_info>
    <org_study_id>FUJIYAMA-Study</org_study_id>
    <secondary_id>UMIN-CTR-C000000324</secondary_id>
    <nct_id>NCT00288717</nct_id>
  </id_info>
  <brief_title>Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients</brief_title>
  <official_title>A Randomized, Comparative Study of the Effects of Candesartan and Telmisartan on the Home Blood Pressure, Glucose and Lipid Metabolism in the Hypertensive Patients With the Accumulation of Visceral Fat by the Central Registration System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saitama Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Non-Profit Organaizaion &quot;LINE&quot;</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Saitama Medical University</source>
  <brief_summary>
    <textblock>
      To investigate the effects of Candesartan and Telmisartan on the home blood pressure, glucose
      and lipid-metabolism in the hypertensive patients with the accumulation of visceral fat by
      the newly developed Tele-medicine system
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, comparative study of the effects of Candesartan and Telmisartan on the home
      blood pressure, glucose and lipid metabolism in the hypertensive patients with the
      accumulation of visceral fat by the central registration system
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2006</start_date>
  <completion_date>September 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Home blood pressure in the early morning</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Home blood pressure at bedtime</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>M/E ratio</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Casual blood pressure</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body fat percentage</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BMI</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood potassium</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL cholesterol</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL cholesterol</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglyceride</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood glucose</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IRI</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HbAlc*</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HOMA-IR</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urinary trace albumin</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Creatinine</measure>
  </secondary_outcome>
  <enrollment>300</enrollment>
  <condition>Hypertension</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Candesartan</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Telmisartan</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Circumference at waist: male ≧85 cm, female ≧90 cm

          -  Hypertensive patient with untreated hypertension, and casual blood pressure of systole
             ≧140 mmHg, or diastole ≧90 mmHg

          -  Hypertensive patient with hypertension under treatment, and casual blood pressure of
             systole ≧130 mmHg, or diastole ≧85 mmHg

        Exclusion Criteria:

          -  Significant hypertensive patient with diastolic blood pressure ≧120 mmHg

          -  Malignant hypertensive patient

          -  Patient with a contraindication to the study drugs (hypersensitivity, significant
             hepatic diseases, pregnant woman)

          -  Patient with urinary protein (qualitative) ＋～＋＋

          -  Patient with familial hyperlipidemia

          -  Other patients judged as ineligible for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hidetomo Nakamoto, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saitama Medical School Department of Renal Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hidetomo Nakamoto, MD</last_name>
    <phone>+81-0492-76-1258</phone>
    <email>nakamo_h@saitama-med.ac.jp</email>
  </overall_contact>
  <location>
    <facility>
      <name>Saitama Medical School Department of Renal Medicine</name>
      <address>
        <city>Saitama City</city>
        <state>Saitama</state>
        <zip>350-0495</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hidetomo Nakamoto, MD</last_name>
      <phone>+81-492-76-1258</phone>
      <email>nakamo_h@saitama-med.ac.jp</email>
    </contact>
    <investigator>
      <last_name>Hidetomo Nakamoto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>January 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2006</study_first_submitted>
  <study_first_submitted_qc>February 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2006</study_first_posted>
  <last_update_submitted>January 9, 2007</last_update_submitted>
  <last_update_submitted_qc>January 9, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 11, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Telmisartan</mesh_term>
    <mesh_term>Candesartan</mesh_term>
    <mesh_term>Candesartan cilexetil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

